The global hyperphosphatemia treatment market is poised for steady growth, according to a recent industry report. The market size, valued at USD 2.58 billion in 2022, is expected to reach USD 3.84 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.1% over the forecast period (2023-2030). Key players The major key players are Sanofi, Takeda Pharmaceutical...